company, announced today that it has completed its leading clinical research in the biopharmaceutical and biotechnology industries Services for the acquisition of PPD (NASDAQ: PPD), a global provider of services, for a purchase price of US$17.
Thermo Fisher releases NGS test kit for myeloid hematological tumors
Time of Update: 2021-12-27
Oncomine Myeloid Assay GX v2 provides a comprehensive combination that requires minimal manual operation time to analyze key biomarkers of major myeloid diseases .
The China Women's Development Foundation and Thermo Fisher officially launch the growth plan for female scientists
Time of Update: 2021-12-27
December 15, 2021, Shanghai-The Women Scientists Growth Plan jointly created by the China Women's Development Foundation (hereinafter referred to as the Women's Foundation) and Thermo Fisher
Thermo Fisher has updated its new coronavirus detection suite to directly detect Omi Keron mutant strains
Time of Update: 2021-12-24
Thermo Fisher Scientific recently announced the update of its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel, which can directly detect the newly emerged SARS-CoV-2 mutant strain Omi Keron .
Thermo Fisher's Q3 revenue increased by 9%, and epidemic-related revenue exceeded US$2 billion
Time of Update: 2021-11-15
Thermo Fisher Scientific reported before the market open on Wednesday that its third-quarter revenue increased by 9% year-on-year due to revenue growth in its three business units .
The future is here, no need to wait for Thermo Fisher's automated NGS system to be launched on the market
Time of Update: 2021-11-12
>The launch of the Genexus purification system has made the high-throughput sequencing industry the first NGS integrated system that automates the entire process from sample to report-the Ion Torrent™ Genexus™ high-throughput sequencing system, which
Thermo Fisher launches a new mobile e-commerce platform-Palm Thermo Fisher
Time of Update: 2021-11-04
The launch of "Handheld Thermo Fisher" will provide researchers with a more convenient and personalized shopping experience .
Thermo Fisher Scientific Approves $3 Billion Share Repurchase
Time of Update: 2021-09-29
September 23, 2021 /PRNewswire/-Thermo Fisher Scientific (NYSE: TMO), a global leader in scientific services, today announced that its board of directors has approved the repurchase worth 3 billion through open market or negotiated transactions Common stock in U.
China Food and Drug Administration: Thermo Fisher Scientific and Rejuvenation Medical Devices are recalling a batch of medical devices
Time of Update: 2021-09-19
reported that the disposable blood transfusion set with needles produced by this company has leaked, and it is now actively recalled.
$192.5 million cooperation, Thermo Fisher to expand the manufacturing of pipette tips in the United States
Time of Update: 2021-09-12
Since the beginning of the COVID-19 pandemic, Thermo Fisher Scientific has invested more than US$180 million to expand its laboratory plastic consumable production and US$600 million to increase global bioprocessing capabilities .
Thermo Fisher Scientific collaborates with Chromsbrow to provide rapid and automated HPLC and UHPLC method development systems
Time of Update: 2021-08-28
To make it easier to use and speed up, the system strategically combines the leading Vanquish HPLC and UHPLC systems and Thermo Scientific Chromeleon chromatography data system (CDS) with ChromSwordAuto and ChromSword autoobust software .
Thermo Fisher Scientific and Suzhou Industrial Park signed a strategic cooperation memorandum
Time of Update: 2021-08-17
(hereinafter referred to as Suzhou Industrial Park) recently signed a strategic cooperation memorandum , Invested in the establishment of Thermo Fisher's first life science research and development center in China
Thermo Fisher Scientific Announces Issuance of U.S. Dollar-denominated Senior Bonds
Time of Update: 2021-08-14
Potential investors should read the prospectus as part of the registration statement, the supplement to the prospectus related to the issuance, and other documents submitted by Thermo Fisher to the SEC to obtain information about Thermo Fisher and the issuance.
Thermo Fisher Scientific updated the customizable TaqMan SARS-CoV-2 mutation panel for detecting delta and lambda mutations
Time of Update: 2021-08-13
The research team was first launched in March 2021 and has a customizable and validated real-time PCR detection menu to identify SARS-CoV-2 mutations .
Three Arrows Started-Thermo Fisher's three new QuantStudio real-time PCR instruments are on the market
Time of Update: 2021-08-09
In the future, QuantStudio1 and QuantStudio 3 IVD&5 IVD real-time fluorescent quantitative PCR instruments will uphold Thermo Fisher's consistent excellent quality and lean services, and work with Chinese users to serve clinical testing and help scientific research breakthroughs .